Luciferase Reporter Assay Service for GPCR-Ligand Interacting Detection

Introduction of Luciferase Reporter Assay

Luciferase reporter assays have become a gold standard in detecting GPCR-ligand interactions, offering an effective way to study GPCR activation in real time. These assays use luciferase enzymes to produce bioluminescence in response to receptor activation, providing quantitative data on ligand efficacy. Scientists have validated the method's efficiency in high-throughput screening and drug discovery, making it an essential tool in modern biopharmaceutical development. Are you facing challenges in detecting GPCR-ligand interactions and optimizing drug candidates? Luciferase reporter assay services at Creative Biolabs streamline the detection of GPCR activation and ligand binding through advanced bioluminescence technologies, helping you accelerate drug discovery and optimize compound screening with high sensitivity and reliability.

With our luciferase reporter assay services, you can:

• Identify lead compounds: Detect and quantify the efficacy of GPCR-targeting compounds with high precision.
• Optimize drug candidates: Monitor real-time receptor activity to refine your compounds for better efficacy and selectivity.
• Increase screening throughput: Our assays support high-throughput screening, allowing you to evaluate hundreds to thousands of compounds simultaneously, accelerating your drug discovery process.

What We Can Offer

At Creative Biolabs, we offer specialized luciferase reporter assay services designed to provide detailed insights into GPCR-ligand interactions. Our services include:

• Custom assay design for specific GPCR targets.
• High-throughput screening for large compound libraries.
• Detailed data analysis to identify potential agonists, antagonists, or allosteric modulators.
• Tailored reports with actionable insights to guide your drug development pipeline.

Discover How We Can Help - Request a Consultation

Workflow

Required Starting Materials

• GPCR Expression Constructs: Custom constructs for your selected GPCR targets.
• Compound Library: A diverse collection of compounds for screening against the GPCR target.
• Cell Line Information: Details of the cell line(s) used for expressing the GPCR, ensuring optimal assay performance.

Publication

By expressing the Eluc-N-ARRB1 fusion protein in CHO and HEK293 cells with the MAC vector, luciferase activity can be measured in response to receptor-ligand interactions. This approach successfully detected luciferase signals in both cell types, demonstrating its ability to quantify protein interactions with high sensitivity. This method is valuable for studying GPCR signaling and can be applied in high-throughput screening and drug discovery.

Fig.1 Assessment of luciferase activity of Eluc-N-ARRB1 expressed from the MAC vector in CHO and HEK293 cells.¹

Highlights

Advanced Technology

We utilize state-of-the-art bioluminescence and reporter assay technologies to ensure precise, reliable results. Our advanced platforms offer cutting-edge techniques for real-time monitoring of GPCR activation, delivering high-quality data that empowers your research and drug discovery efforts.

High Sensitivity and Accuracy

Detect even subtle GPCR-ligand interactions with minimal background interference. Our assays provide exceptional sensitivity, allowing you to identify weak or transient receptor activations that could be missed by other methods, ensuring accurate results for compound efficacy screening.

Customizable Assays for Specific Targets

Our assays are fully customizable, ensuring compatibility with your unique research needs and offering flexibility across a broad spectrum of therapeutic targets.

Real-Time Data for Enhanced Decision Making

Our luciferase assays allow for real-time tracking of ligand-GPCR interactions, offering dynamic insights into receptor activation. This allows you to assess compound efficacy and kinetics in real-time, improving decision-making and optimizing drug candidate selection.

Experience the Creative Biolabs Advantage - Get a Quote Today

Customer Reviews

1. Improved Screening Efficiency
   Using Creative Biolabs' Luciferase Reporter Assay in our research has significantly improved our high-throughput screening efficiency. We identified several promising GPCR-targeting compounds faster than before.
   Sarah T., 2024.
2. Accurate Data for Compound Optimization
   The real-time data collection from the Luciferase Reporter Assay provided us with the necessary insights to refine our lead compounds, resulting in more selective GPCR agonists.
   Dr. M.K., 2023.
3. Reliable and Customizable Service
   The customized luciferase assays offered by Creative Biolabs were essential in our drug discovery project. The high sensitivity of the assays helped us detect low-affinity interactions with ease. Liam G., 2024.

FAQs

Extended Services

• GPCR Engineering: We offer services for generating and optimizing GPCR expression constructs tailored to your research needs.
• High-Throughput Screening: Beyond luciferase assays, we offer comprehensive screening solutions for various target types, enhancing your drug discovery process.
• Data Analysis and Consultation: Our team can assist with interpreting complex assay data and provide strategic insights to guide your project forward.

At Creative Biolabs, we offer luciferase reporter assay services that can enhance the efficiency of your GPCR-ligand interaction studies. From assay design to high-throughput screening and data analysis, our solutions are crafted to accelerate your drug discovery efforts. Feel free to reach out for a consultation or to learn more about how we can help optimize your drug discovery process.

Reference

1. Uno, Narumi, et al. "A luciferase complementation assay system using transferable mouse artificial chromosomes to monitor protein–protein interactions mediated by G protein-coupled receptors." Cytotechnology 70 (2018): 1499-1508. DOI: 10.1007/s10616-018-0231-7. Distributed under Open Access license CC BY 4.0, without modification.

Download our brochure